LCM
MDT icon

Liberty Capital Management’s Medtronic MDT Stock Holding History

Liberty Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,125
Closed -$207K – 121
2019
Q2 		$207K Buy
+2,125
New +$194K 0.09% 119
2018
Q4 		– Sell
-2,125
Closed -$209K – 101
2018
Q3 		$209K Buy
+2,125
New +$196K 0.11% 103
2018
Q1 		– Sell
-2,125
Closed -$182K – 181
2017
Q4 		$182K Sell
2,125
-261
-11% -$20.9K 0.1% 122
2017
Q3 		$187K Buy
2,386
+75
+3% +$6.23K 0.1% 124
2017
Q2 		$202K Buy
2,311
+200
+9% +$16.9K 0.12% 106
2017
Q1 		$170K Buy
2,111
+661
+46% +$51.6K 0.1% 113
2016
Q4 		$110K Buy
1,450
+450
+45% +$35.4K 0.07% 124
2016
Q3 		$86K Buy
+1,000
New +$87.1K 0.06% 134

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Liberty Capital Management's MDT Position: Q3 2019 in Review

Liberty Capital Management sold out of Medtronic (MDT) in Q3 2019, closing a stake of 2,125 shares — an estimated $207K sold.

Liberty Capital Management first reported a position in MDT in Q3 2016 and held it in 8 quarters. The position peaked at $209K in Q3 2018. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Liberty Capital Management reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Liberty Capital Management sold 2,125 Medtronic shares in Q3 2019, an estimated $207K.
  • Liberty Capital Management first reported a position in Medtronic in Q3 2016 and held it in 8 quarters.
  • Liberty Capital Management's Medtronic position peaked at $209K in Q3 2018.
  • 1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Liberty Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.